Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III

Gut

Volumn 56, Issue 6, 2007, Pages 742-744

  Baillie, John ^a   Kimberly, James ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; SECRETIN;

BILE FLOW; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; EXERCISE TEST; HEALTH INSURANCE; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MANOMETRY; NOTE; PRIORITY JOURNAL; VATER PAPILLA STENOSIS;

CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; GASTROINTESTINAL AGENTS; HUMANS; MANOMETRY; SECRETIN; SPHINCTER OF ODDI DYSFUNCTION;

EID: 34249823647     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.111278     Document Type: Note

References (17)

1. Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989;320:82-7.
2. Baillie J. Sphincter of Oddi dysfunction: overdue for an overhaul. Am J Gastroenterol 2005;100:1217-20.
3. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-90.
4. Craig AG, Toouli J. Sphincterotomy for biliary sphincter of Oddi dysfunction. In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
5. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet, 2003;26, 361:1447-55.
6. Menees S, Elta GH. Sphincter of Oddi dysfunction. Curr Treat Options Gastroenterol 2005;8:109-15.
7. Tarnasky PR, Palesch YY, Cunningham JT, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfonction. Gastroenterology 1998;115:1518-24.
8. Freeman M, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
9. Sherman S, Troiano FP, Hawes RH, et al. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990;36:462-6.
10. Gottlieb K, Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest Clin N Am 1998;8:87-114.
11. Pereira SP, Gilliams A, Sgouros SN, et al. Prospective comparison or secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction Types II and III. GUT 2007;56:809- 13.
12. Barish MA, Yucel EK, Ferrucci JT. Magnetic resonance cholangio-pancreatography. N Engl J Med 1999,341:258-64.
13. Hogan WJ, Sherman S, Pasricha P, et al. Sphincter of Oddi manometry. Gastrointest Endosc 1997;45:342-8.
14. Mates C, Cappeliez O, Winant C, et al. MR imaging of the pancreas: a pictorial tour. Radiographics 2002;22:e2.
15. Wehrmann T, Seifert H, Seipp M, et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998;30:702-7.
16. Merkle EM, Baillie J. Exocrine pancreatic function: evaluation with MR imaging before and after secretin stimulation. Am J Gastroenterol 2006;101:137-8.
17. Schneider AR, Hammerstingl R, Heller M, et al. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency? A comparison with noninvasive exocrine pancreatic function tests. J Clin Gastroenterol 2006;40:851-5.